15 results
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
28 Aug 23
Current report (foreign)
4:49pm
Executive Officer of Alveda Pharmaceuticals Inc., a leading supplier of pharmaceuticals to the Canadian health care market, from 2006 until November … invested in our Shares as of March 31, 2018 with the total return of the S&P/TSX Capped Health Care Index:
The performance trend shown by the above
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
25 Jul 23
Medicenna Presents at National Brain Tumor Society's Research Round Table
8:00am
partnerships across science, health care, policy, and business sectors. We fund treatments-focused research and convene those most critical to curing brain
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
22 Aug 22
Current report (foreign)
11:39am
and President and Chief Executive Officer of Alveda Pharmaceuticals Inc., a leading supplier of pharmaceuticals to the Canadian health care market
20-F
2022 FY
MDNAF
Medicenna Therapeutics Corp.
22 Jun 22
Annual report (foreign)
5:04pm
of pharmaceuticals to the Canadian health care market, from 2006 until November 2015. Alveda was acquired by Teligent, Inc. (formerly IGI Laboratories, Inc
6-K
EX-99.1
9fds77th3965fjxufk
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.1
hwpgb1286tx afon1n
1 Sep 21
Current report (foreign)
8:00am
40-F
EX-99.1
y7an79c5hea
28 May 21
Annual report (Canada)
12:12pm
6-K
EX-99.2
3suvmu mkwaz7z1
30 Dec 20
Current report (foreign)
9:10pm
6-K
EX-99.1
mraxxcdv cpcw
4 Sep 20
Current report (foreign)
2:50pm
S-8
EX-99.4
galip4qubs7rumosphn
31 Jul 20
Registration of securities for employees
8:43am
S-8
EX-99.1
eocx7bputws4m a9kis8
31 Jul 20
Registration of securities for employees
8:43am
F-10
EX-4.1
jf2h9i6n p6dbp
3 Jun 20
Registration of securities (Canada)
3:54pm
F-10
EX-4.4
2t086yhlto7 dog
3 Jun 20
Registration of securities (Canada)
3:54pm
D/A
brw2zh3 yzzwfq9
20 Apr 20
$9.22M in equity, sold $9.22M, 6 investors
2:25pm
- Prev
- 1
- Next